Estimating the Impact of Extragenital Warts versus Genital Warts on Quality of Life in Immunocompetent Indian Adult Patients: A Comparative Cross-Sectional Study.
DLQI
HPV
extra-genital
genital
quality of life
warts
Journal
Indian journal of dermatology
ISSN: 1998-3611
Titre abrégé: Indian J Dermatol
Pays: India
ID NLM: 0370750
Informations de publication
Date de publication:
Historique:
entrez:
29
4
2021
pubmed:
30
4
2021
medline:
30
4
2021
Statut:
ppublish
Résumé
Extra-genital warts (EGWs) affect 7-10% of population. Even though a plethora of studies have been conducted to assess the impact of genital warts (GWs) showing a significant impact on the quality of life but surprisingly, barely any data has been collected on the impact of EGWs on quality of life. This cross-sectional study aimed at comparing the magnitude of EGWs on health-related quality of life and various variables with that of GWs. The study consisted of two groups of immunocompetent adults, each with 100 patients aged 18 years or above, attending the skin outpatient department at our tertiary center between April 2018 and March 2019 and consented to participate. Group A consisted of patients with EGWs and group B comprised of patients with GWs. All patients were asked to fulfill the validated Hindi hard copy of the Dermatology Life Quality Index (DLQI) questionnaire. The mean DLQI score of patients with EGWs was 8.73 ± 0.84 and that of patients with GWs was 5.83 ± 0.83 ( EGWs inflict a severe negative impact on the quality of life. Owing to its notorious persistence and recurrence, healthcare professionals must educate patients on how to prevent the spread and recurrence, discuss details of available treatment modalities while keeping in view the psychological and sociological impact.
Sections du résumé
BACKGROUND
BACKGROUND
Extra-genital warts (EGWs) affect 7-10% of population. Even though a plethora of studies have been conducted to assess the impact of genital warts (GWs) showing a significant impact on the quality of life but surprisingly, barely any data has been collected on the impact of EGWs on quality of life.
AIMS AND OBJECTIVE
OBJECTIVE
This cross-sectional study aimed at comparing the magnitude of EGWs on health-related quality of life and various variables with that of GWs.
PATIENTS AND METHODS
METHODS
The study consisted of two groups of immunocompetent adults, each with 100 patients aged 18 years or above, attending the skin outpatient department at our tertiary center between April 2018 and March 2019 and consented to participate. Group A consisted of patients with EGWs and group B comprised of patients with GWs. All patients were asked to fulfill the validated Hindi hard copy of the Dermatology Life Quality Index (DLQI) questionnaire.
RESULTS
RESULTS
The mean DLQI score of patients with EGWs was 8.73 ± 0.84 and that of patients with GWs was 5.83 ± 0.83 (
CONCLUSIONS
CONCLUSIONS
EGWs inflict a severe negative impact on the quality of life. Owing to its notorious persistence and recurrence, healthcare professionals must educate patients on how to prevent the spread and recurrence, discuss details of available treatment modalities while keeping in view the psychological and sociological impact.
Identifiants
pubmed: 33911292
doi: 10.4103/ijd.IJD_290_19
pii: IJD-66-44
pmc: PMC8061486
doi:
Types de publication
Journal Article
Langues
eng
Pagination
44-48Informations de copyright
Copyright: © 2021 Indian Journal of Dermatology.
Déclaration de conflit d'intérêts
There are no conflicts of interest.
Références
An Bras Dermatol. 2017 May-Jun;92(3):427-429
pubmed: 29186268
Indian J Dermatol. 2015 Mar-Apr;60(2):118-29
pubmed: 25814698
Viral Immunol. 2018 Jun;31(5):346-351
pubmed: 29717924
Pediatr Dermatol. 2003 May-Jun;20(3):268-71
pubmed: 12787281
Natl Med J India. 2004 Nov-Dec;17(6):310-9
pubmed: 15736552
Int J STD AIDS. 2014 Nov;25(13):949-55
pubmed: 24671715
BMC Res Notes. 2010 Nov 04;3:280
pubmed: 21050431
Australas J Dermatol. 2003 Aug;44(3):169-73
pubmed: 12869040
Salud Publica Mex. 2018 Nov-Dic;60(6):624-632
pubmed: 30699267
BMC Public Health. 2013 Nov 12;13:1065
pubmed: 24215264
Sex Transm Infect. 2011 Oct;87(6):458-63
pubmed: 21636616
Clin Cosmet Investig Dermatol. 2018 Jun 11;11:289-295
pubmed: 29928139
Qual Life Res. 2005 Feb;14(1):119-32
pubmed: 15789946
An Bras Dermatol. 2011 Mar-Apr;86(2):306-17
pubmed: 21603814
N Engl J Med. 2003 Feb 6;348(6):518-27
pubmed: 12571259